These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 24296660)

  • 21. Identification and characterisation of a novel GHR defect disrupting the polypyrimidine tract and resulting in GH insensitivity.
    David A; Miraki-Moud F; Shaw NJ; Savage MO; Clark AJ; Metherell LA
    Eur J Endocrinol; 2010 Jan; 162(1):37-42. PubMed ID: 19812236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and biochemical consequences of an intragenic growth hormone receptor (GHR) deletion in a large Chinese pedigree.
    Klammt J; Shen S; Kiess W; Kratzsch J; Stobbe H; Vogel M; Luo F; Pfäffle R
    Clin Endocrinol (Oxf); 2015 Mar; 82(3):453-61. PubMed ID: 25196842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of dominant-negative growth hormone receptor variants reveals a potential therapeutic target for short stature.
    Andrews A; Cottrell E; Maharaj A; Ladha T; Williams J; Schilbach K; Kaisinger LR; Perry JRB; Metherell LA; McCormick PJ; Storr HL
    Eur J Endocrinol; 2023 Apr; 188(4):353-365. PubMed ID: 36943306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Novel, Heterozygous, de novo Splicing Variant Affecting the Intracellular Domain of the Growth Hormone Receptor, and Causing a Mild Short Stature.
    Giannakopoulos A; Papanastasiou AD; Zarkadis IK; Andrew SF; Rosenfeld RG; Efthymiadou A; Chrysis D; Hwa V
    Horm Res Paediatr; 2024; 97(4):397-403. PubMed ID: 37725936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterozygous nonsense mutation in exon 3 of the growth hormone receptor (GHR) in severe GH insensitivity (Laron syndrome) and the issue of the origin and function of the GHRd3 isoform.
    Pantel J; Grulich-Henn J; Bettendorf M; Strasburger CJ; Heinrich U; Amselem S
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1705-10. PubMed ID: 12679461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A half-century of studies of growth hormone insensitivity/Laron syndrome: A historical perspective.
    Rosenbloom AL
    Growth Horm IGF Res; 2016 Jun; 28():46-50. PubMed ID: 26276451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenotypic spectrum and responses to recombinant human IGF1 (rhIGF1) therapy in patients with homozygous intronic pseudoexon growth hormone receptor mutation.
    Chatterjee S; Shapiro L; Rose SJ; Mushtaq T; Clayton PE; Ten SB; Bhangoo A; Kumbattae U; Dias R; Savage MO; Metherell LA; Storr HL
    Eur J Endocrinol; 2018 May; 178(5):481-489. PubMed ID: 29500309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compound heterozygosity for two GHR missense mutations in a patient affected by Laron Syndrome: a case report.
    Moia S; Tessaris D; Einaudi S; de Sanctis L; Bona G; Bellone S; Prodam F
    Ital J Pediatr; 2017 Oct; 43(1):94. PubMed ID: 29025428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The first homozygous mutation (S226I) in the highly-conserved WSXWS-like motif of the GH receptor causing Laron syndrome: supression of GH secretion by GnRH analogue therapy not restored by dihydrotestosterone administration.
    Jorge AA; Souza SC; Arnhold IJ; Mendonca BB
    Clin Endocrinol (Oxf); 2004 Jan; 60(1):36-40. PubMed ID: 14678285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The exon 3-deleted/full-length growth hormone receptor polymorphism and response to growth hormone therapy in growth hormone deficiency and Turner syndrome: a multicenter study.
    Baş F; Darendeliler F; Aycan Z; Çetinkaya E; Berberoğlu M; Sıklar Z; Öcal G; Timirci Ö; Çetinkaya S; Darcan Ş; Gökşen Şimşek D; Bideci A; Cinaz P; Böber E; Demir K; Bereket A; Turan S; Atabek ME; Tütüncüler F; Isbir T; Bozkurt N; Kabataş Eryılmaz S; Uzunhan O; Küçükemre Aydın B; Bundak R
    Horm Res Paediatr; 2012; 77(2):85-93. PubMed ID: 22456308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel growth hormone receptor mutation in a Chinese patient with Laron syndrome.
    Hui HN; Metherell LA; Ng KL; Savage MO; Camacho-Hübner C; Clark AJ
    J Pediatr Endocrinol Metab; 2005 Feb; 18(2):209-13. PubMed ID: 15751611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Novel nonsense mutation (p.Y113X) in the human growth hormone receptor gene in a Brazilian patient with Laron syndrome].
    Diniz ET; Jorge AA; Arnhold IJ; Rosenbloom AL; Bandeira F
    Arq Bras Endocrinol Metabol; 2008 Nov; 52(8):1264-71. PubMed ID: 19169479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An intronic growth hormone receptor mutation causing activation of a pseudoexon is associated with a broad spectrum of growth hormone insensitivity phenotypes.
    David A; Camacho-Hübner C; Bhangoo A; Rose SJ; Miraki-Moud F; Akker SA; Butler GE; Ten S; Clayton PE; Clark AJ; Savage MO; Metherell LA
    J Clin Endocrinol Metab; 2007 Feb; 92(2):655-9. PubMed ID: 17148568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth hormone (GH) insensitivity and insulin-like growth factor-I deficiency in Inuit subjects and an Ecuadorian cohort: functional studies of two codon 180 GH receptor gene mutations.
    Fang P; Girgis R; Little BM; Pratt KL; Guevara-Aguirre J; Hwa V; Rosenfeld RG
    J Clin Endocrinol Metab; 2008 Mar; 93(3):1030-7. PubMed ID: 18073295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin-like growth factor-I treatment in primary growth hormone insensitivity: effect of recombinant human IGF-I (rhIGF-I) and rhIGF-I/rhIGF-binding protein-3 complex.
    Tonella P; Flück CE; Mullis PE
    Horm Res Paediatr; 2010; 73(2):140-7. PubMed ID: 20190552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel C-terminal growth hormone receptor (GHR) mutation results in impaired GHR-STAT5 but normal STAT-3 signaling.
    Tiulpakov A; Rubtsov P; Dedov I; Peterkova V; Bezlepkina O; Chrousos GP; Hochberg Z
    J Clin Endocrinol Metab; 2005 Jan; 90(1):542-7. PubMed ID: 15536163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical review 112: Does serum growth hormone (GH) binding protein reflect human GH receptor function?
    Amit T; Youdim MB; Hochberg Z
    J Clin Endocrinol Metab; 2000 Mar; 85(3):927-32. PubMed ID: 10720017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diverse deletions in the growth hormone receptor gene cause growth hormone insensitivity syndrome.
    Gastier JM; Berg MA; Vesterhus P; Reiter EO; Francke U
    Hum Mutat; 2000 Oct; 16(4):323-33. PubMed ID: 11013443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A short isoform of the human growth hormone receptor functions as a dominant negative inhibitor of the full-length receptor and generates large amounts of binding protein.
    Ross RJ; Esposito N; Shen XY; Von Laue S; Chew SL; Dobson PR; Postel-Vinay MC; Finidori J
    Mol Endocrinol; 1997 Mar; 11(3):265-73. PubMed ID: 9058373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential regulation by growth hormone (GH) of insulin-like growth factor I and GH receptor/binding protein gene expression in rat liver.
    Maiter D; Walker JL; Adam E; Moatsstaats B; Mulumba N; Ketelslegers JM; Underwood LE
    Endocrinology; 1992 Jun; 130(6):3257-64. PubMed ID: 1375898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.